How does cueing work?
Parkinson's disease affects the internal motor control pathways in the brain, particularly those controlling automatic movement. Cueing (the provision of an external stimulus to move) activates goal orientated motor pathways in different regions of the brain bypassing the area affected by Parkinson's. This explains why sometimes people with Parkinson's may be able to dance yet not walk. The use of cueing can lead to improved walking ability.
Has the efficacy of the gaitQ system been validated?
The efficacy of a prototype system was tested through a pilot clinical study in 2019. Results indicated that the system offered significant benefits to people with Parkinson's by decreasing both the number of freezing episodes and their duration, as well as providing improvements to the individual's stride and step symmetry. It is this system that gaitQ is taking through development.
Is one device needed on each leg? Can I wear it on just one leg?
Having a device on both legs allows our system to better capture freezing events and obtain more characteristics of the user's gait. In the future this will contribute to better freeze detection and cueing, and more in-depth gait analytics.
Is the device easy to put on?
We know from speaking to and working with people with Parkinson's that we needed a device that is simple, quick to put on and is discrete. Our product team have worked hard to achieve this. The devices can be put on either leg, any way up and have a fastening that is easy to use. We are currently embarking on an extensive testing period and will make any adjustments needed to improve our product.
When will the gaitQ system be available?
We are currently focussed on developing our system by collecting more walking data and conducting further product testing. Subject to device approvals, we are working towards a product launch in 2022.